Skip to main content
. Author manuscript; available in PMC: 2012 Jul 15.
Published in final edited form as: J Immunol. 2011 Jun 15;187(2):1023–1030. doi: 10.4049/jimmunol.1004195

Table II.

Patient Characteristics

CAV
(n=40)
no CAV
(n=32)
p value
Age 58 +/− 11 y 60 +/− 14 y 0.63
Male Gender 62% 67% 1.00
Race/Ethnicity
   African American
21% 20% 0.65
   Caucasian 42% 51%
   Hispanic 28% 17%
   Asian 4% 0%
   Other 5% 12%
Time post-transplant to sample acquisition 10.2 +/− 4.2 y 7.4 +/− 3.0 y 0.01
History of Treated Humoral Rejection 6% 5% 0.86
History of Treated Cellular Rejection 18% 42% 0.06